Het rapport
Geverifieerd nieuws over financiering, hoofdkantoren en leiderschap van 's werelds meest innovatieve bedrijven
3 rapporten en meer
Dagelijks bijgewerkt met de nieuwste marktinformatie
Fundraising
AdvanCell
AdvanCell Raises $315M Series D for Targeted Alpha Therapies
AdvanCell closed an oversubscribed, upsized $315 million Series D led by Ally Bridge Group and co-led by Alpha Wave to advance ADVC001 toward Phase 3 and expand U.S. manufacturing.
SalesTools Research
Jul 15, 2026
2 min read•$315M
Fundraising
AdvanCell
AdvanCell Raises $112M in Series C
AdvanCell, a HealthTech company based in San Francisco, CA, has raised $112M in Series C at a $700M valuation led by Deerfield Management, Logos Capital.
Fundraising News Team
Feb 1, 2025
0 min read
HealthTech
AdvanCell
AdvanCell raises $112M Series C at $700M valuation
AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...
Editorial Team
Feb 1, 2025
0 min read•$112M
Pagina 1
Tonen van 3 rapporten • Pagina 1 • Categorie: all
Loop voor op de markt
Ontvang wekelijkse inzichten in uw inbox. Geen spam, alleen intelligentie.



